1. Home
  2. ZS vs HLN Comparison

ZS vs HLN Comparison

Compare ZS & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zscaler Inc.

ZS

Zscaler Inc.

HOLD

Current Price

$222.80

Market Cap

52.0B

Sector

Technology

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$10.11

Market Cap

44.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZS
HLN
Founded
2007
2022
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Package Goods/Cosmetics
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
52.0B
44.5B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ZS
HLN
Price
$222.80
$10.11
Analyst Decision
Buy
Hold
Analyst Count
34
1
Target Price
$323.73
N/A
AVG Volume (30 Days)
1.6M
9.4M
Earning Date
11-25-2025
07-31-2025
Dividend Yield
N/A
1.81%
EPS Growth
N/A
41.64
EPS
N/A
0.23
Revenue
$2,833,272,000.00
$15,096,588,575.00
Revenue This Year
$27.01
$1.51
Revenue Next Year
$19.32
$4.67
P/E Ratio
N/A
$43.72
Revenue Growth
23.24
N/A
52 Week Low
$164.78
$8.71
52 Week High
$336.99
$11.42

Technical Indicators

Market Signals
Indicator
ZS
HLN
Relative Strength Index (RSI) 30.00 62.81
Support Level $217.23 $10.05
Resistance Level $231.06 $10.15
Average True Range (ATR) 4.93 0.12
MACD 1.47 0.01
Stochastic Oscillator 30.66 90.62

Price Performance

Historical Comparison
ZS
HLN

About ZS Zscaler Inc.

Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: